Granted Patent B2

US 12,239,124 · App. 17/421,134 · Granted Mar 4, 2025

Inventors: Fabien Ectors (Gesves, BE); Luc Grobet (Esneux, BE); Delphine Connan (Gesves, BE); Nadine Dupuis (Burg-Reuland, BE)

Assignee: Cryoport Belgium S.A.

A01N1/0221

Abstract

Claims (48)

1. A liquid composition for cryopreservation of a biological material comprising

a polar aprotic solvent selected from dimethylsulfoxide (DMSO) and dimethylformamide (DMF),

a monohydric or polyhydric alcohol selected from ethylene glycol, propylene glycol, glycerol, erythritol, sorbitol, mannitol, xylitol, volemitol, methanol, ethanol, isopropanol, butanol and pentanol;

an unbranched polysaccharide selected from the group consisting of sucrose, trehalose, lactulose, melibiose, lactobionate, raffinose and cellulose;

dextran; and

polyvinyl alcohol;

and wherein the dextran comprises Dextran 1, Dextran 40, and Dextran 70.

2. The liquid composition for cryopreservation of a biological material according to claim 1 comprising DMSO, ethylene glycol, sucrose, dextran and polyvinyl alcohol.

3. The liquid composition according to claim 2 , wherein the composition comprises substantially equal amounts of DMSO and ethylene glycol and a concentration of sucrose which is at least 8 times that of dextran.

4. The liquid composition according to claim 1 comprising at least 0.8% (v/v) of a polar aprotic solvent;

at least 0.8% (v/v) of a monohydric or polyhydric alcohol;

at least 0.5% (w/v) of unbranched polysaccharide;

at least 0.037% (w/v) of dextran;

at least 0.015% (w/v) polyvinyl alcohol; and

up to 100% (v/v/) of a diluent.

5. The liquid composition according to claim 1 , comprising:

13.0-23.0% (v/v) of a polar aprotic solvent;

13.0-23.0% (v/v) of a monohydric or polyhydric alcohol;

9.0-31.0% (w/v) of an unbranched polysaccharide;

0.60-22.0% (w/v), of dextran;

0.30-4.0% (w/v) polyvinyl alcohol, and/or

up to 100% (v/v) of a diluent;

or a dilution of said liquid composition in said diluent.

6. The liquid composition according to claim 1 , comprising at least 15% (v/v) of a polar aprotic solvent, at least 15% (v/v) of a monohydric or polyhydric alcohol, at least 15% (w/v) of an unbranched polysaccharide, at least 2% (w/v) of dextran and about 0.9% (w/v) polyvinyl alcohol.

7. The liquid composition according to claim 4 , wherein said diluent is a balanced salt solution, preferably phosphate buffered saline (PBS).

8. The liquid composition according to claim 1 , comprising

17.7% (v/v) DMSO;

17.7% (v/v) ethylene glycol;

22.7% (w/v) sucrose;

0.88% (w/v) Dextran 1;

0.088% (w/v) Dextran 40;

0.88% (w/v) Dextran 70; and

0.88% (w/v) polyvinyl alcohol.

9. The liquid composition according to claim 1 , wherein the liquid composition does not comprise proteins, polypeptides or peptides.

10. A method for preserving a biological material comprising the steps of

providing a biological material;

contacting the biological material with the liquid composition according to claim 1 ; and

cooling and/or heating the biological material in the liquid composition.

11. The method of claim 10 , which comprises contacting the biological material with at least one dilution of a composition comprising:

13.0-23.0% (v/v) of a polar aprotic solvent;

13.0-23.0% (v/v) of a monohydric or polyhydric alcohol;

9.0-31.0% (w/v) of an unbranched polysaccharide;

0.60-22.0% (w/v), of dextran;

0.30-4.0% (w/v) polyvinyl alcohol, and/or

up to 100% (v/v) of a diluent;

before contacting the biological material with said composition.

12. The method according to claim 10 wherein said cooling comprises freezing the biological material or vitrification of the biological material.

13. The method according to claim 10 , wherein the biological material is selected from the group of stem cells, gametes and embryos.

Assignments (2)

Priority Claims (1)

Continuity (1)

References Cited (43)